Mode
Text Size
Log in / Sign up
N/A Completed N=102 Randomized Double-blind Treatment

A Comparative Study of Two Dry Needling Interventions for Plantar Heel Pain

Plantar Fascitis · Myofacial Pain Syndromes · Trigger Point Pain, Myofascial
Source: ClinicalTrials.gov NCT03236779 ↗
Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Jan 2021
Primary outcomePrimary: Foot Health Status Questioner (FHSQ) PAIN — 38.8; 40.4; 73.4; 71.9 score on a scale

Summary

This is a clinical trial that will be done in the state of Kuwait, at the physical rehabilitation medicine hospital. the participants will be recruited from all over Kuwait, there is a clinical registry upon the ethical committee in Kuwait assigned by the ministry of health.

Outcome Measures

OutcomeResultp-value
PRIMARY
Foot Health Status Questioner (FHSQ) PAIN
38.8; 40.4; 73.4; 71.9; 70.1; 67.4
SECONDARY
VAS Maximum
7.6; 7.5; 6.2; 5.5; 5.4; 5.3
SECONDARY
The Quality of Life (QoL) Will be Assessed With the EuroQoL-5 Dimensions (EQ-5D)
0.63; 0.67; 0.78; 0.76; 0.72; 0.74

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of PHP in accordance with the Clinical Guidelines linked to the International Classification of Function, Disability, and Health from the Orthopedic Section of the American Physical Therapy Association
  • Age greater than 21 years according to the Kuwaiti law.
  • History of plantar heel pain for greater than one month.
  • Walking 50 meters without any support
  • Having MTPs on initial physical examination on plantar and calf muscles
  • Accepting to be treated by a male physiotherapist.
  • Capacity to understand the study and the informed consent, as well as having signed the document.

Exclusion Criteria

  • - Needle phobia
  • Allergy from needles or hypersensitivity to metals
  • Presence of coagulopathy or use of anticoagulants
  • Presence of peripheral arterial vascular disease
  • Pregnancy
  • Dermatological disease with the dry needling area
  • The presence of a chronic medical condition that might preclude participation in the study such as malignancy, systemic inflammatory disorders (e.g. psoriatic arthritis, ankylosing spondylitis, septic arthritis), neurological diseases, polyneuropathy, mononeuropathy.
  • Treatment of plantar heel pain with needling or acupuncture during last 4 weeks.
  • A history of injection therapy in the heel in the previous three months.
  • Previous history of foot surgery or fracture.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03236779). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search